UPDATE: VistaGen says regulators couldn’t sniff out abuse potential of its nasal spray for social anxiety

Diversity Drives Better Outcomes

New Social Anxiety Disorder Drug Differentiates Mechanism of Action

Expert: There is a Dire Need to Improve, More Effectively Treat Mental Health Disorders for Returning Veterans

This Drug Has the Potential to Become the First FDA-Approved on-Demand Treatment for Social Anxiety

Psychiatric drugs were once a $30 billion business. Analysts say these 9 companies could revive it.

Karyopharm taps long­time Pfiz­er, Am­gen vet to steer the ship; With Mer­ck in the rearview mir­ror, Roger Perl­mut­ter stakes his claim to a CEO job — and it's a sur­pris­ing choice

BioSpace Movers & Shakers, May 7

Chutes & Ladders—Former Merck R&D chief Perlmutter takes reins at Eikon, applying Nobel-winning tech to drug discovery